Screener / SEC EDGAR /CIK 0001757073 /10-K filed Feb 12, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Dental Equipment & Supplies

Envista Holdings Corp NVST

Compare with peers Embed
FY2025 at a glance

Sales up 8.3%, free cash flow down to $230.4M

XBRL, from each 10-K
RevenueStatements
$2.7B from $2.5B in FY2024
FY2017FY2025
Net incomeStatements
$47.0M from -$1.1B in FY2024
FY2017FY2025
Free cash flowStatements
$230.4M from $302.7M in FY2024
FY2017FY2025
EPS (diluted)Statements
$0.28 from $-6.50 in FY2024
FY2017FY2025
Operating marginStatements
7.9% from -41.4% in FY2024
FY2017FY2025
Total debtStatements
$1.4B from $1.5B in FY2024
FY2017FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (43)
EPS (ttm)
3.85
Sales (ttm)
2.9B
Net income (ttm)
633.6M
Sales growth
+8.3%
EPS growth
-
Sales Q/Q
+3.2%
Free cash flow
242.0M
Gross margin
55.9%
Oper. margin
25.4%
Net margin
22.0%
FCF margin
8.4%
R&D / sales
4.2%
Dividend
-
Debt/Eq
0.46
Curr. ratio
2.45
Cash
1.2B
Op. cash flow (ttm)
301.8M
EBITDA
332.1M
EBITDA margin
12.2%
Net debt
270.2M
Quick ratio
2.10
Interest cover
4.69
ROIC
1.3%
FCF after stock pay
192.8M
Debt / FCF (years)
6.20
Goodwill / assets
41.5%
Oper. margin low 5y
-41.4%
Tax rate
73.5%
Stock pay / sales
1.4%
Shares out.
160.3M
Shares Y/Y
-1.7%
Book / share
19.26
Cash / share
7.23
Sales / share
17.95
Asset turnover
0.51
Inventory turns
4.28
Days sales out.
58
Sales 3Y CAGR
+1.9%
Sales 5Y CAGR
+7.1%
EPS 3Y CAGR
-41.1%
EPS 5Y CAGR
+7.0%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2017 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 2.7B -0.4% a year Net income 47.0M -20.7% a year
FY2017 revenue 2.8B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-20-001914 FY2017 net income 301.1M · NetIncomeLoss, 0001628280-20-001914 2.8B FY2017 FY2018 revenue 2.8B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-21-002508 FY2018 net income 230.7M · NetIncomeLoss, 0001628280-21-002508 2.8B FY2018 FY2019 revenue 2.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-22-000010 FY2019 net income 217.6M · NetIncomeLoss, 0001757073-22-000010 2.3B FY2019 FY2020 revenue 1.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-23-000010 FY2020 net income 33.3M · NetIncomeLoss, 0001757073-23-000010 1.9B FY2020 FY2021 revenue 2.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-24-000019 FY2021 net income 340.5M · NetIncomeLoss, 0001757073-24-000019 2.5B FY2021 FY2022 revenue 2.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-25-000007 FY2022 net income 243.1M · NetIncomeLoss, 0001757073-25-000007 2.6B FY2022 FY2023 revenue 2.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-26-000011 FY2023 net income -100.2M · NetIncomeLoss, 0001757073-26-000011 2.6B FY2023 FY2024 revenue 2.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-26-000011 FY2024 net income -1.1B · NetIncomeLoss, 0001757073-26-000011 2.5B FY2024 FY2025 revenue 2.7B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001757073-26-000011 FY2025 net income 47.0M · NetIncomeLoss, 0001757073-26-000011 2.7B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2017 to FY2025 (8 years).

From the same starting line, FY2017 to FY2025

Revenue, net income and free cash flow, each set to 100 in FY2017. What happened, from the 10-Ks. Not a forecast.

FY2017 = 100
40 60 80 100 Revenue: $2.8B in FY2017, $2.7B in FY2025 REVENUE $2.7B · 1.0x Free cash flow: $310.2M in FY2017, $230.4M in FY2025 FREE CASH FLOW $230.4M · 0.7x FY2017 = 100FY2021FY2025
Revenue 1.0x $2.8B to $2.7B
Free cash flow 0.7x $310.2M to $230.4M

Growth per share, FY2017 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share -23.4% a year FY2017 $2.35 to FY2025 $0.28, 8 years
Book value per share -9.8% a year FY2018 $37.71 to FY2025 $18.36, 7 years
Free cash flow per share -7.0% a year FY2017 $2.43 to FY2025 $1.36, 8 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $0.28$18.36$1.36
Dec 31, 2024 -$6.50$17.04$1.76
Dec 31, 2023 -$0.60$25.01$1.30
Dec 31, 2022 $1.37$23.69$0.60
Dec 31, 2021 $1.92$22.85$1.73
Dec 31, 2020 $0.20$22.67$1.44
Dec 31, 2019 $1.60$25.95$2.34
Dec 31, 2018 $1.80$37.71$2.56
Dec 31, 2017 $2.35-$2.43

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $2.0B
  • − All liabilities (total assets less equity) $2.6B
  • = Net current asset value -$546.1M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $3.1B
  • − Goodwill $2.4B
  • − Other intangible assets $627.2M
  • = Tangible book value $120.9M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result. This company does not tag total liabilities, so total assets less equity is used (it includes any non-controlling interest).

NVST against Health care peers

Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+4.8%+20.2%
+8.3%91st of 155 · median +10.5%
Net margin
-4.1%15.3%
22.0%21st of 154 · median 6.8%
Return on equity
-5.2%18.5%
20.5%28th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
8.4%83rd of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
0.4632nd of 108 · median 0.69
NVST and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
NVST Envista Holdings Corp$2.9B +8.3%55.9%22.0%20.5%8.4%0.46
BKD Brookdale Senior Living Inc.$2.9B +2.2%27.6%-1.3%-0.5%-
RVTY Revvity$2.9B +3.7%-8.6%3.5%20.1%0.36
NTRA Natera, Inc.$2.9B +35.9%--5.7%-8.8%1.8%0.04
HIMS Hims & Hers Health, Inc.$2.9B +59.0%63.8%-6.7%-53.7%0.3%-
MEDP Medpace Holdings, Inc.$2.8B +20.0%-18.2%88.5%23.5%-
All 162 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by segment

From $2.5B of sales to $340.5M of profit FY2021

  • Specialty Products & Technologies $1.5B
  • Equipment & Consumables $1.0B
Revenue to Gross profit: $1.4BRevenue to Cost of revenue: $1.1BGross profit to Operating profit: $306.2MGross profit to Operating expenses: $1.1BOperating profit to Net profit: $306.2MOther income to Net profit: $34.3MOperating expenses to R&D: $100.5MOperating expenses to SG&A: $1.0B Revenue: $2.5B REVENUE $2.5B +30% Y/Y Gross profit: $1.4B · 57% margin GROSS PROFIT $1.4B 57% margin · +35% Y/Y Cost of revenue: $1.1B · 43% of revenue COST OF REVENUE $1.1B 43% of revenue Operating profit: $306.2M · 12% margin OPERATING PROFIT $306.2M 12% margin · +604% Y/Y Other income: $34.3M · 1% of revenue OTHER INCOME $34.3M 1% of revenue Operating expenses: $1.1B · 45% of revenue OPERATING EXPENSES $1.1B 45% of revenue Net profit: $340.5M · 14% margin NET PROFIT $340.5M 14% margin · +923% Y/Y R&D: $100.5M · 4% of revenue R&D $100.5M 4% of revenue SG&A: $1.0B · 41% of revenue SG&A $1.0B 41% of revenue

From $2.6B of sales to $243.1M of profit FY2022

  • Specialty Products & Technologies $1.6B
  • Equipment & Consumables $970.5M
Revenue to Gross profit: $1.5BRevenue to Cost of revenue: $1.1BGross profit to Operating profit: $319.2MGross profit to Operating expenses: $1.2BOperating profit to Net profit: $243.1MOperating profit to Tax & other: $76.1MOperating expenses to R&D: $100.1MOperating expenses to SG&A: $1.1B Revenue: $2.6B REVENUE $2.6B +2% Y/Y Gross profit: $1.5B · 57% margin GROSS PROFIT $1.5B 57% margin · +3% Y/Y Cost of revenue: $1.1B · 43% of revenue COST OF REVENUE $1.1B 43% of revenue Operating profit: $319.2M · 12% margin OPERATING PROFIT $319.2M 12% margin · +4% Y/Y Operating expenses: $1.2B · 45% of revenue OPERATING EXPENSES $1.2B 45% of revenue Net profit: $243.1M · 9% margin NET PROFIT $243.1M 9% margin · −29% Y/Y Tax & other: $76.1M · 3% of revenue TAX & OTHER $76.1M 3% of revenue R&D: $100.1M · 4% of revenue R&D $100.1M 4% of revenue SG&A: $1.1B · 41% of revenue SG&A $1.1B 41% of revenue

From $2.7B of sales to $47.0M of profit FY2025

  • Specialty Products & Technologies $1.8B
  • Equipment & Consumables $966.7M
Revenue to Gross profit: $1.5BRevenue to Cost of revenue: $1.2BGross profit to Operating profit: $216.1MGross profit to Operating expenses: $1.3BOperating profit to Net profit: $47.0MOperating profit to Tax & other: $169.1MOperating expenses to R&D: $114.0MOperating expenses to SG&A: $1.2B Revenue: $2.7B REVENUE $2.7B +8% Y/Y Gross profit: $1.5B · 55% margin GROSS PROFIT $1.5B 55% margin · +8% Y/Y Cost of revenue: $1.2B · 45% of revenue COST OF REVENUE $1.2B 45% of revenue Operating profit: $216.1M · 8% margin OPERATING PROFIT $216.1M 8% margin Operating expenses: $1.3B · 47% of revenue OPERATING EXPENSES $1.3B 47% of revenue Net profit: $47.0M · 2% margin NET PROFIT $47.0M 2% margin Tax & other: $169.1M · 6% of revenue TAX & OTHER $169.1M 6% of revenue R&D: $114.0M · 4% of revenue R&D $114.0M 4% of revenue SG&A: $1.2B · 43% of revenue SG&A $1.2B 43% of revenue

Where each $100 of sales went

FY2021
FY2022
FY2025
  • Cost of revenue
  • Sales, admin & other
  • Net profit
  • R&D
  • Tax & other

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity 1.5% FY2020: 0.9% net income ÷ equity
Net margin 1.7% FY2020: 1.7% profit per $ of sales: 47.0M ÷ 2.7B
Asset turnover 0.48× FY2020: 0.28× sales per $ of assets: 2.7B ÷ 5.7B
Leverage 1.83× FY2020: 1.85× assets per $ of equity: 5.7B ÷ 3.1B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin above the peer median
    22.0% vs 6.8%
  • Gross margin down over 5 years
    54.7% → 54.7%
  • Return on equity above 15%
    20.5%
  • A profit in 7 of 9 years
Net margin, FY2017 to FY2025: 10.7% to 1.7%

Balance sheet

  • Interest covered less than 5 times
    Operating income is 4.7× interest expense
  • Debt smaller than equity
    Debt / equity 0.46 on the latest balance sheet (peer median 0.69)
  • Current assets cover current liabilities
    Current ratio 2.45
  • Net debt under 3 years of free cash flow
    $270.2M net debt, 1.1 years
Debt / equity at each year end, FY2017 to FY2025: 0.00 to 0.47

Cash and shareholders

  • Free cash flow positive in every one of 9 years
    $230.4M last year
  • Share count up over 5 years
    +3.1%
  • Cash from operations above net income
    $275.7M vs $47.0M
Free cash flow, FY2017 to FY2025: 310.2M to 230.4M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Remaining performance obligations

Signed, not yet recognized $173.1M revenue under contracts the company has not delivered yet, Oct 2, 2026 · +9.1% on a year earlier

Contract liabilities

Paid in advance $211.1M cash received before delivery, not yet recognized as revenue, Oct 2, 2026 · +6.7% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

NVST's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 9. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue2.7B
FY2017: 2.8BFY2018: 2.8BFY2019: 2.3BFY2020: 1.9BFY2021: 2.5BFY2022: 2.6BFY2023: 2.6BFY2024: 2.5BFY2025: 2.7B FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income47.0M
FY2017: 301.1MFY2018: 230.7MFY2019: 217.6MFY2020: 33.3MFY2021: 340.5MFY2022: 243.1MFY2023: -100.2MFY2024: -1.1BFY2025: 47.0M FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow230.4M
FY2017: 310.2MFY2018: 327.9MFY2019: 319.7MFY2020: 236.2MFY2021: 306.9MFY2022: 107.0MFY2023: 217.5MFY2024: 302.7MFY2025: 230.4M FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow after stock pay192.8M
FY2017: 297.9MFY2018: 314.6MFY2019: 301.3MFY2020: 213.6MFY2021: 278.7MFY2022: 76.5MFY2023: 186.8MFY2024: 267.4MFY2025: 192.8M FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
EPS (diluted)0.28
FY2017: 2.35FY2018: 1.80FY2019: 1.60FY2020: 0.20FY2021: 1.92FY2022: 1.37FY2023: -0.60FY2024: -6.50FY2025: 0.28 FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Diluted shares169.2M
FY2017: 127.9MFY2018: 127.9MFY2019: 136.4MFY2020: 164.1MFY2021: 177.6MFY2022: 177.6MFY2023: 166.9MFY2024: 172.2MFY2025: 169.2M FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Specialty Products & Technologies 1.8B64.5% +8.4%
Equipment & Consumables 966.7M35.5% +8.1%

10-K 0001757073-26-000011, segment and revenue notes (XBRL).

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
North America 1.4B51.3% +6.9%
United States 1.3B47.1% +6.5%
All other (each country individually less than 5% of total sales) 1.2B45.7% +11.6%
Western Europe 615.3M22.6% +12.7%
Emerging markets 586.2M21.6% +8.8%
China 194.4M7.1% +0.5%
Other developed markets 122.8M4.5% +2.1%

10-K 0001757073-26-000011, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Specialty Products & Technologies1.5B1.6B1.6B1.6B1.8B
Equipment & Consumables1.0B970.5M924.1M894.2M966.7M
Sum of segments2.5B2.6B2.6B2.5B2.7B

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Specialty Productsand Technologies272.3M268.6M232.1M89.9M191.2M
Equipmentand Consumables153.8M172.4M156.3M152.3M158.0M
Corporate and other-119.9M-121.8M-356.9M--

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2.8B2.8B2.3B1.9B2.5B2.6B2.6B2.5B2.7B
Cost of revenue1.2B1.2B935.6M874.3M1.1B1.1B1.1B1.1B1.2B
Gross profit1.6B1.6B1.3B1.1B1.4B1.5B1.4B1.4B1.5B
R&D172.4M172.0M133.1M86.7M100.5M100.1M93.8M99.1M114.0M
SG&A1.1B1.1B980.4M924.6M1.0B1.1B1.1B1.2B1.2B
Operating income386.6M298.4M235.7M43.5M306.2M319.2M31.5M-1.0B216.1M
Interest expense003.5M62.5M54.1M38.4M63.4M54.7M46.1M
Pretax income386.7M301.1M233.7M-20.0M254.5M283.9M-54.9M-1.1B177.2M
Income tax85.6M70.4M49.6M-62.5M-9.0M45.9M45.3M33.9M130.2M
Net income301.1M230.7M217.6M33.3M340.5M243.1M-100.2M-1.1B47.0M
EPS (diluted)2.351.801.600.201.921.37-0.60-6.500.28
Diluted shares127.9M127.9M136.4M164.1M177.6M177.6M166.9M172.2M169.2M
Depreciation & amortization121.4M130.0M120.4M121.7M117.8M137.8M135.6M123.1M116.0M
EBITDA508.0M428.4M356.1M165.2M424.0M457.0M167.1M-915.1M332.1M
Gross margin57.7%56.3%59.1%54.7%56.9%57.4%56.1%54.7%54.7%
Operating margin13.8%10.5%10.3%2.3%12.2%12.4%1.2%-41.4%7.9%
Net margin10.7%8.1%9.5%1.7%13.6%9.5%-3.9%-44.6%1.7%
Revenue growth-+1.2%-19.7%-15.6%+30.1%+2.4%-0.1%-2.2%+8.3%
EPS growth--23.4%-11.1%-87.5%+860%-28.6%to a loss--

Cash flow

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow359.1M400.1M397.5M283.9M361.6M182.7M275.7M336.5M275.7M
Capital spending48.9M72.2M77.8M47.7M54.7M75.7M58.2M33.8M45.3M
Free cash flow310.2M327.9M319.7M236.2M306.9M107.0M217.5M302.7M230.4M
Stock-based pay (added back)12.3M13.3M18.4M22.6M28.2M30.5M30.7M35.3M37.6M
Free cash flow after stock pay297.9M314.6M301.3M213.6M278.7M76.5M186.8M267.4M192.8M
Acquisitions-0040.7M2.1M696.2M00-
Debt repaid-----500K288.8M100.0M0
Investing cash flow-54.9M-75.5M-78.4M-69.1M262.7M-657.3M-62.4M-54.6M-51.1M
Financing cash flow-304.2M-324.6M-107.7M492.5M-465.6M12.5M118.9M-103.7M-170.9M

Stock-based pay and leases

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)12.3M13.3M18.4M22.6M28.2M30.5M30.7M35.3M37.6M
Stock-based pay / revenue0.4%0.5%0.8%1.2%1.1%1.2%1.2%1.4%1.4%
Operating lease cost--39.6M35.7M32.4M31.7M34.2M38.6M41.4M
Operating lease cash paid-037.0M36.7M37.5M31.6M34.5M42.8M44.7M
Right-of-use assets-182.0M200.1M162.7M128.1M131.8M125.1M142.8M142.1M
Operating lease liabilities-191.0M212.7M186.3M144.1M148.4M140.2M153.4M149.4M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NVST/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.